Article
Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice
2022-07-22
Abstract excerpt
<h4>Background: </h4> Rifaximin has been increasingly applied in irritable bowel syndrome (IBS) treatment. Whether there were differences in the effects of rifaximin on microbiota from different intestinal segments, especially the small intestine where rifaximin predominantly acted, has not been confirmed. Methods In this study, we used Trichinella spiralis infection to induce post infectious irritable bowel synd...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 087d75fe-cdf5-5ad8-b5ff-81c2817c5b0b
- DOI
- 10.21203/rs.3.rs-1794729/v1
